We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vascular Solutions, Inc.(VASC) Stopping Their Red Ink and Bl -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (1)4/5/2005 4:36:50 PM
From: Arthur Radley  Read Replies (1) | Respond to of 22
Just received the 2004 Annual Report...excellent reading!
I liked especially the concluding paragraph..
"....we believe that we will continue to set new quarterly sales records each quarter throughout 2005. For the entire 2005 we expect net sales of between $35Milllion and $40 million, WITHOUT counting any contribution from our 3x3 trauma bandage. Looking even further out, we believe that 2006 can continue this trend of rapid quarterly revenue growth, and that 2007 could be a break-out year for Vascular Solutions as our new thrombin based surgical products are launched into an existing market that exceeds $200 million with only one competitor."